IL117723A - Indole-3-carbonyl and indole-3-sulfonyl derivatives platelet activating factor antagonist pharmaceutical compositions containing them and uses thereof - Google Patents

Indole-3-carbonyl and indole-3-sulfonyl derivatives platelet activating factor antagonist pharmaceutical compositions containing them and uses thereof

Info

Publication number
IL117723A
IL117723A IL11772396A IL11772396A IL117723A IL 117723 A IL117723 A IL 117723A IL 11772396 A IL11772396 A IL 11772396A IL 11772396 A IL11772396 A IL 11772396A IL 117723 A IL117723 A IL 117723A
Authority
IL
Israel
Prior art keywords
indole
carbonyl
pharmaceutical compositions
compositions containing
activating factor
Prior art date
Application number
IL11772396A
Other languages
English (en)
Other versions
IL117723A0 (en
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL117723A0 publication Critical patent/IL117723A0/xx
Publication of IL117723A publication Critical patent/IL117723A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11772396A 1995-04-19 1996-03-29 Indole-3-carbonyl and indole-3-sulfonyl derivatives platelet activating factor antagonist pharmaceutical compositions containing them and uses thereof IL117723A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/424,911 US5567711A (en) 1995-04-19 1995-04-19 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists

Publications (2)

Publication Number Publication Date
IL117723A0 IL117723A0 (en) 1996-07-23
IL117723A true IL117723A (en) 2000-07-26

Family

ID=23684396

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11772396A IL117723A (en) 1995-04-19 1996-03-29 Indole-3-carbonyl and indole-3-sulfonyl derivatives platelet activating factor antagonist pharmaceutical compositions containing them and uses thereof

Country Status (13)

Country Link
US (3) US5567711A (de)
EP (1) EP0821685B1 (de)
JP (1) JPH11503758A (de)
KR (1) KR19990007863A (de)
AT (1) ATE206425T1 (de)
AU (1) AU705237B2 (de)
CA (1) CA2218020A1 (de)
DE (1) DE69615676T2 (de)
DK (1) DK0821685T3 (de)
ES (1) ES2164240T3 (de)
IL (1) IL117723A (de)
PT (1) PT821685E (de)
WO (1) WO1996033196A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968933A (en) * 1994-08-26 1999-10-19 Auckland Division Cancer Society Of New Zealand Inc. DNA-targeted alkylating agents
US6630496B1 (en) 1996-08-26 2003-10-07 Genetics Institute Llc Inhibitors of phospholipase enzymes
EP2583675A1 (de) * 1998-02-02 2013-04-24 Trustees Of Tufts College Verwendung von Dipetidylpeptidasehemmer zur Regulierung des Glukosemetabolismus
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6828344B1 (en) 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
DE19815026A1 (de) * 1998-04-03 1999-10-07 Hoechst Schering Agrevo Gmbh Substituierte Piperidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
US6747023B1 (en) 1998-08-11 2004-06-08 Daiichi Pharmaceutical Co., Ltd. Sulfonyl derivatives
AU2319100A (en) * 1999-01-28 2000-08-18 Nippon Shinyaku Co. Ltd. Amide derivatives and drug compositions
DE10000739A1 (de) * 2000-01-11 2001-07-12 Merck Patent Gmbh Piperidin- und Piperazinderivate
WO2001058869A2 (en) 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
DE60122939T2 (de) * 2000-12-21 2007-01-11 Nitromed, Inc., Bedford Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren
DK1474425T3 (da) * 2002-01-07 2006-09-25 Eisai Co Ltd Deazapuriner og anvendelser deraf
SE0201635D0 (sv) * 2002-05-30 2002-05-30 Astrazeneca Ab Novel compounds
TW200307542A (en) * 2002-05-30 2003-12-16 Astrazeneca Ab Novel compounds
SE0202241D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Novel Compounds
TW200401641A (en) 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
DE10253426B4 (de) * 2002-11-15 2005-09-22 Elbion Ag Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
SE0301569D0 (sv) * 2003-05-27 2003-05-27 Astrazeneca Ab Novel compounds
SE0302232D0 (sv) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
US7157471B2 (en) 2003-08-25 2007-01-02 Boehringer Ingelheim International Gmbh Haloalkyl- and piperidine-substituted benzimidazole-derivatives
CA2536787C (en) * 2003-08-25 2012-02-21 Boehringer Ingelheim International Gmbh Haloalkyl- and piperidine-substituted benzimidazole-derivatives
US7504401B2 (en) * 2003-08-29 2009-03-17 Locus Pharmaceuticals, Inc. Anti-cancer agents and uses thereof
SE0303180D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
US7723360B2 (en) * 2004-08-06 2010-05-25 Boehringer Ingelheim International Gmbh Alkyl-and piperidine-substituted benzimidazole derivatives
GB0500604D0 (en) * 2005-01-13 2005-02-16 Astrazeneca Ab Novel process
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
EP2392571A3 (de) * 2005-07-29 2012-03-14 F. Hoffmann-La Roche AG Indol-3-yl-Carbonyl-Piperidin- und Piperazinderivate
US7645752B2 (en) * 2006-01-13 2010-01-12 Wyeth Llc Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors
JP2009538289A (ja) * 2006-05-26 2009-11-05 アストラゼネカ・アクチエボラーグ ビアリールまたはヘテロアリール置換インドール
US20080280891A1 (en) * 2006-06-27 2008-11-13 Locus Pharmaceuticals, Inc. Anti-cancer agents and uses thereof
HUE044867T2 (hu) 2011-05-12 2019-11-28 Proteostasis Therapeutics Inc Proteosztázis szabályzók
EP2968285A4 (de) * 2013-03-13 2016-12-21 Flatley Discovery Lab Verbindungen und verfahren zur behandlung von zystischer fibrose
KR102129842B1 (ko) 2013-10-02 2020-07-06 주식회사 대웅제약 술포닐인돌 유도체 및 이의 제조방법
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT98673B (pt) * 1990-08-15 1999-01-29 British Bio Technology Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de benzimidazole e de seus intermediarios
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
GB9107398D0 (en) * 1991-04-09 1991-05-22 British Bio Technology Compounds
IE922293A1 (en) * 1991-07-17 1993-01-27 Abbott Lab Platelet activating factor antagonists
GB9200245D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles

Also Published As

Publication number Publication date
MX9708032A (es) 1997-11-29
EP0821685B1 (de) 2001-10-04
PT821685E (pt) 2002-03-28
ES2164240T3 (es) 2002-02-16
DE69615676T2 (de) 2002-07-11
CA2218020A1 (en) 1996-10-24
JPH11503758A (ja) 1999-03-30
DE69615676D1 (de) 2001-11-08
WO1996033196A1 (en) 1996-10-24
KR19990007863A (ko) 1999-01-25
US5643922A (en) 1997-07-01
DK0821685T3 (da) 2002-01-21
EP0821685A1 (de) 1998-02-04
US5654305A (en) 1997-08-05
US5567711A (en) 1996-10-22
IL117723A0 (en) 1996-07-23
AU5429596A (en) 1996-11-07
ATE206425T1 (de) 2001-10-15
AU705237B2 (en) 1999-05-20

Similar Documents

Publication Publication Date Title
IL117723A (en) Indole-3-carbonyl and indole-3-sulfonyl derivatives platelet activating factor antagonist pharmaceutical compositions containing them and uses thereof
IL111963A0 (en) Platelet activating factor antagonists: imidazopyridine indoles
CA2498047A1 (en) Novel imidazole compounds as transforming growth factor (tgf) inhibitors
EP2165708A3 (de) Neue Pyrazol-Verbindungen als Hemmer des transformierenden Wachstumsfaktors (TGF)
TW200504069A (en) Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors
MXPA05009245A (es) Nuevos compuestos de pirazina como inhibidores del factor de crecimiento transformante (tgf).
CA2434277A1 (en) Substituted alkylamine derivatives and methods of use
CA2401229A1 (en) Aryl fused azapolycyclic compounds
AU6049690A (en) Small cyclic platelet aggregation inhibitors
HUT60253A (en) Process for producing pyridazone derivatives and pharmaceutical compositions comprising such derivatives as active ingredient
DE60128258D1 (de) Indanylderivate zur Behandlung von Atemwegserkrankungen
MEP9509A (en) Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
YU20999A (sh) Heterociklični derivati koji inhibiraju faktor xa
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ES2036926A1 (es) "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
MD523G2 (ro) Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
CA2280328A1 (en) C11 carbamates of macrolide antibacterials
CA2412047A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
RU95110110A (ru) Производные бензофурана, способ их получения, фармкомпозиция и способ лечения
EP0595924A4 (en) Platelet activating factor antagonists
EE05329B1 (et) GlyT-1 inhibiitorid, neid sisaldavad kompositsioonid, nende kasutamine ja nende valmistamise vahehendid
RU93044224A (ru) Фармацевтическая композиция, обладающая агонистической активностью для 5 нт1 - подобных рецепторов
ATE206917T1 (de) 2-phenyl-3-azoylbenzothiophene zur minderung des intraokularen drucks
HUP0401912A3 (en) Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees